Search by Algolia
Never Miss Important Company Updates Again
Get AI-powered summaries of SEC filings delivered to your inbox
Follow your favorite stocks and get email alerts when they release important updates. Completely free.
Oncolytics Biotech Reports $9.4 Million Net Loss in Q2 2026, Seeks Additional Financing
Oncolytics Biotech Reports $9.2 Million Net Loss in Q1 2026, Increases R&D Spending
Oncolytics Biotech Reports $28.8 Million Net Loss and Strategic Transition to Nevada